Evaxion Biotech A/S (EVAX)
NASDAQ·Healthcare·Biotechnology
$2.85
+1.61%
Mkt Cap $19.45M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$9.50
Range $9.00 – $10.00
Implied Upside
+233.9%
Consensus $9.50 vs current $2.85
NASDAQ·Healthcare·Biotechnology
$2.85
+1.61%
Mkt Cap $19.45M
No recent rating data.
Price Target (4 analysts)
$9.50
Range $9.00 – $10.00
+233.9%
Consensus $9.50 vs current $2.85